Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD

摘要

Objective Iron deficiency is a common complication in patients with IBD and oral iron therapy is suggested to exacerbate IBD symptoms. We performed an open-labelled clinical trial to compare the effects of per oral (PO) versus intravenous (IV) iron replacement therapy (IRT).